Increased sensitivity to light-induced damage in a mouse model of autosomal dominant retinal disease

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 5, 2007, Pages 1942-1951

  White, D Alan ^a,b   Hauswirth, William W ^a,b   Kaushal, Shalesh ^a,b   Lewin, Alfred S ^a,b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CONTROLLED STUDY; ELECTRORETINOGRAPHY; GENE EXPRESSION; GLYCOSYLATION; HEMIZYGOTE; HISTOLOGY; LIGHT EXPOSURE; MICROSCOPY; MORPHOMETRICS; MOUSE; NICK END LABELING; NONHUMAN; OPHTHALMOSCOPY; PHENOTYPE; PHOTORECEPTOR; PRIORITY JOURNAL; RETINA; RETINA DISEASE; RETINA INJURY; RETINA ROD; SENSITIVITY AND SENSIBILITY; TRANSGENIC MOUSE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; WILD TYPE; ADENO ASSOCIATED VIRUS; ANIMAL; C57BL MOUSE; DISEASE MODEL; DOMINANT GENE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE THERAPY; GENETICS; LIGHT; MALE; MOUSE MUTANT; PATHOLOGY; POLYMERASE CHAIN REACTION; RADIATION EXPOSURE; RADIATION INJURY; RETINA DEGENERATION; TRANSGENE;

RHODOPSIN;

ANIMALS; APOPTOSIS; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE THERAPY; GENES, DOMINANT; IN SITU NICK-END LABELING; LIGHT; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; PHOTORECEPTORS, VERTEBRATE; POLYMERASE CHAIN REACTION; RADIATION INJURIES, EXPERIMENTAL; RETINA; RETINAL DEGENERATION; RHODOPSIN; TRANSGENES;

EID: 34250190624     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-1131     Document Type: Article

References (40)

1. Flannery JG, Farber DB, Bird AC, Bok D. Degenerative changes in a retina affected with autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1989;30:191-211.
2. Hims MM, Diager SP, Inglehearn CF. Retinitis pigmentosa: genes, proteins and prospects. Dev Ophthalmol. 2003;37:109-125.
3. Farrar GJ, Kenna PF, Humphries P. On the genetics of retinitis pigmentosa and on mutation-independent approaches to therapeutic intervention. EMBO J. 2002;21:857-864.
4. Stricker HM, Ding XQ, Quiambao A, Fliesler SJ, Naash MI. The Cys214→Ser mutation in peripherin/rds causes a loss-of-function phenotype in transgenic mice. Biochem J. 2005;388:605-613.
5. Farber DB, Flannery JG, Bird AC, Shuster T, Bok D. Histopathological and biochemical studies on donor eyes affected with retinitis pigmentosa. Prog Clin Biol Res. 1987;247:53-67.
6. Humphries P, Kenna P, Farrar GJ. On the molecular-genetics of retinitis-pigmentosa. Science. 1992;256:804-808.
7. Dryja TP, McGee TL, Reichel E, et al. A point mutation of the rhodopsin gene in one form of retinitis pigmentosa. Nature. 1990; 343:364-366.
8. Rivolta C, Sharon D, DeAngelis MM, Dryja TP. Retinitis pigmentosa and allied diseases: numerous diseases, genes, and inheritance patterns. Hum Mol Genet. 2002;11:1219-1227.
9. Wilson JH, Wensel TG. The nature of dominant mutations of rhodopsin and implications for gene therapy. Mol Neurobiol. 2003;28:149-158.
10. Berson EL. Retinitis pigmentosa: unfolding its mystery. Proc Natl Acad Sci USA. 1996;93:4526-4528.
11. Li T, Sandberg MA, Pawlyk BS, et al. Effect of vitamin A supplementation on rhodopsin mutants threonine-17→methionine and proline-347→serine in transgenic mice and in cell cultures. Proc Natl Acad Sci USA. 1998;95:11933-11938.
12. Kaushal S, Khorana HG. Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa. Biochemistry. 1994;33:6121-6128.
13. Lewin AS, Drenser KA, Hauswirth WW, et al. Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa. Nat Med. 1998;4:967-971.
14. LaVail MM, Yasumura D, Matthes MT, et al. Ribozyme rescue of photoreceptor cells in P23H transgenic rats: long-term survival and late-stage therapy. Proc Natl Acad Sci USA. 2000;97:11488-11493.
15. Drenser KA, Timmers AM, Hauswirth WW, Lewin AS. Ribozyme-targeted destruction of RNA associated with autosomal-dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1998;39:681-689.
16. Lem J, Krasnoperova NV, Calvert PD, et al. Morphological, physiological, and biochemical changes in rhodopsin knockout mice. Proc Natl Acad Sci USA. 1999;96:736-741.
17. Cideciyan AV, Jacobson SG, Aleman TS, et al. In vivo dynamics of retinal injury and repair in the rhodopsin mutant dog model of human retinitis pigmentosa. Proc Natl Acad Sci USA. 2005;102: 5233-5238.
18. Hao W, Wenzel A, Obin MS, et al. Evidence for two apoptotic pathways in light-induced retinal degeneration. Nat Genet. 2002; 32:254-260.
19. Wang M, Lam TT, Tso MO, Naash MI. Expression of a mutant opsin gene increases the susceptibility of the retina to light damage. Vis Neurosci. 1997;14:55-62.
20. Wenzel A, Reme CE, Williams TP, Hafezi F, Grimm C. The Rpe65 Leu450Met variation increases retinal resistance against light-induced degeneration by slowing rhodopsin regeneration. J Neurosci. 2001;21:53-58.
21. Grimm C, Wenzel A, Hafezi F, Yu S, Redmond TM, Reme CE. Protection of Rpe65-deficient mice identifies rhodopsin as a mediator of light-induced retinal degeneration. Nat Genet. 2000;25: 63-66.
22. Keller C, Grimm C, Wenzel A, Hafezi F, Reme C. Protective effect of halothane anesthesia on retinal light damage: inhibition of metabolic rhodopsin regeneration. Invest Ophthalmol Vis Sci. 2001;42:476-480.
23. Sieving PA, Chaudhry P, Kondo M, et al. Inhibition of the visual cycle in vivo by 13-cis retinoic acid protects from light damage and provides a mechanism for night blindness in isotretinoin therapy. Proc Natl Acad Sci USA. 2001;98:1835-1840.
24. Aonuma H, Yamazaki R, Watanabe I. Retinal cell death by light damage. Jpn J Ophthalmol. 1999;43:171-179.
25. Fliesler SJ, Rayborn ME, Hollyfield JG. Membrane morphogenesis in retinal rod outer segments: inhibition by tunicamycin. J Cell Biol. 1985;100:574-587.
26. Fliesler SJ, Basinger SF. Tunicamycin blocks the incorporation of opsin into retinal rod outer segment membranes. Proc Natl Acad Sci USA. 1985;82:1116-1120.
27. Zhu L, Jang GF, Jastrzebska B, et al. A naturally occurring mutation of the opsin gene (T4R) in dogs affects glycosylation and stability of the G protein-coupled receptor. J Biol Chem. 2004;279:53828-53839.
28. Kaushal S, Ridge KD, Khorana HG. Structure and function in rhodopsin: the role of asparagine-linked glycosylation. Proc Natl Acad Sci USA. 1994;91:4024-4028.
29. Paskowitz DM, La Vail MM, Duncan JL. Light and inherited retinal degeneration. Br J Ophthalmol. 2006;90:1060-1066.
30. Mendes HF, van der SJ, Chapple JP, Cheetham ME. Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy. Trends Mol Med. 2005;11:177-185.
31. Besharse JC, Wetzel MG. Immunocytochemical localization of opsin in rod photoreceptors during periods of rapid disc assembly. J Neurocytol. 1995;24:371-388.
32. Wenzel A, Grimm C, Samardzija M, Reme CE. Molecular mechanisms of light-induced photoreceptor apoptosis and neuroprotection for retinal degeneration. Prog Retin Eye Res. 2005;24:275-306.
33. Wenzel A, Grimm C, Seeliger MW, et al. Prevention of photoreceptor apoptosis by activation of the glucocorticoid receptor. Invest Ophthalmol Vis Sci. 2001;42:1653-1659.
34. Cao W, Tombran-Tink J, Elias R, Sezate S, Mrazek D, McGinnis JF. In vivo protection of photoreceptors from light damage by pigment epithelium-derived factor. Invest Ophthalmol Vis Sci. 2001; 42:1646-1652.
35. Miyazaki M, Ikeda Y, Yonemitsu Y, et al. Simian lentiviral vector-mediated retinal gene transfer of pigment epithelium-derived factor protects retinal degeneration and electrical defect in Royal College of Surgeons rats. Gene Ther. 2003;10:1503-1511.
36. Cayouette M, Smith SB, Becerra SP, Gravel C. Pigment epithelium-derived factor delays the death of photoreceptors in mouse models of inherited retinal degenerations. Neurobiol Dis. 1999;6:523-532.
37. Lawwill T, Crockett RS, Currier G, Rosenberg RB. Review of the macaque model of light damage with implications for the use of ophthalmic instrumentation. Vision Res. 1980;20:1113-1115.
38. Michels M, Dawson WW, Feldman RB, Jarolem K. Infrared: an unseen and unnecessary hazard in ophthalmic devices. Ophthalmology. 1987;94:143-148.
39. Meyers SM, Bonner RF. Yellow filter to decrease the risk of light damage to the retina during vitrectomy. Am J Ophthalmol. 1982; 94:677.
40. McKechnie NM, Ghafour IM. Potential retinal light damage from the use of therapeutic instruments. Trans Ophthalmol Soc U K. 1982;102:140-146.